XML 37 R21.htm IDEA: XBRL DOCUMENT v3.24.1
Fair Value Measurements (Tables)
12 Months Ended
Feb. 03, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Instruments
The fair value of the Company’s financial instruments as of February 3, 2024 and January 28, 2023 are as follows:

($000)20232022
Cash and cash equivalents (Level 1)
$4,872,446 $4,551,876 
Restricted cash and cash equivalents (Level 1)
$62,995 $60,365 
Schedule of Fair Value of Assets and Liabilities The fair value measurement for funds with quoted market prices in active markets (Level 1) are as follows:
($000)20232022
Nonqualified deferred compensation program (Level 1)$165,582 $155,496